Ozoralizumab
Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis[1].
Product Specifications
CAS Number
[1167985-17-2]
Product Name Alternative
ATN-103; PF-5230896
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ozoralizumab.html
Purity
99.80
Solubility
10 mM in DMSO
Smiles
[Ozoralizumab]
Molecular Weight
(38.43 kDa)
References & Citations
[1]Ishiwatari-Ogata C, et, al. Ozoralizumab, a Humanized Anti-TNFα NANOBODY® Compound, Exhibits Efficacy Not Only at the Onset of Arthritis in a Human TNF Transgenic Mouse but Also During Secondary Failure of Administration of an Anti-TNFα IgG. Front Immunol. 2022 Feb 22;13:853008.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
47748151 3x 1.0 µg DNA
TRIM14 CRISPR All-in-one AAV vector set (with saCas9)(Human)
Ask
View Details 
MBS7184637 Inquire
Rabbit anti-Escherichia coli (strain 8739/DSM 1576/Crooks) MDTB Polyclonal Antibody
Ask
View Details 122805 100 µg
ABCC2 (Canalicular Multispecific Organic Anion Transporter 1, ATP-binding Cassette Sub-family C Member 2, Canalicular Multidrug Resistance Protein, Multidrug Resistance-associated Protein 2, CMOAT, CMOAT1, CMRP, MRP2)
Ask
View Details 